Biyoelement (Mineral ve Eser Element) Hastalıklarının Nörolojik Bulguları ve Tedavisi
Özet
Eser elementlerin ve minerallerin eksikliği veya fazlalığı, metabolik bozukluklara yol açarak nörolojik sistem üzerinde ciddi patolojik etkilere neden olabilmektedir. Demir, selenyum, çinko, bakır ve iyot gibi temel elementlerin homeostazındaki bozulmalar; nörodejenerasyon, bilişsel gerilik ve motor fonksiyon kayıpları gibi klinik tabloları tetikleyebilmektedir. Erken teşhis ve uygun mineral desteği, bu elementlerle ilişkili nörolojik hastalıkların yönetimi ve prognozun iyileştirilmesi açısından kritik öneme sahiptir.
Deficiencies or imbalances of trace elements and minerals can disrupt metabolic processes, leading to significant pathological effects on the neurological system. Disruptions in the homeostasis of essential elements such as iron, selenium, zinc, copper, and iodine can trigger clinical conditions, including neurodegeneration, cognitive impairment, and loss of motor function. Early diagnosis and appropriate mineral supplementation are critical for managing these trace element-related neurological disorders and improving patient prognosis.
Referanslar
Mehri A. Trace Elements in Human Nutrition (II) - An Update. Int J Prev Med. 2020 Jan 3;11:2.
Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr. 2006 Dec;84;6:1261-76.
Beard JL. Why iron deficiency is important in infant development. J Nutr. 2008 Dec;138;12;:2534-6.
Baker RD, Greer FR; Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010 Nov;126;5:1040-50.
Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med. 1991 Sep 5;325;10:687-94.
Gupta PM, Perrine CG, Mei Z, Scanlon KS. Iron, Anemia, and Iron Deficiency Anemia among Young Children in the United States. Nutrients. 2016 May 30;8;6:330.
Yager JY, Hartfield DS. Neurologic manifestations of iron deficiency in childhood. Pediatr Neurol. 2002 Aug;27;2:85-92.
Meyer E, Kurian MA, Hayflick SJ. Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms. Annu Rev Genomics Hum Genet. 2015;16:257-79.
Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 1998 May;67(5 Suppl):972S-977S.
Colombelli C, Aoun M, Tiranti V. Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron. J Inherit Metab Dis. 2015 Jan;38:1:123-36.
Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003 Jan 2;348:1:33-40.
Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009 Feb;46:2:73-80.
Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology. 2008 Apr 29;70(18):1623-9.
Venco P, Bonora M, Giorgi C, Papaleo E, Iuso A, Prokisch H, et al. Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca²⁺. Front Genet. 2015 May 19;6:185.
Jiang P, Mizushima N. Autophagy and human diseases. Cell Res. 2014 Jan;24:1:69-79.
Domellöf M. Iron requirements in infancy. Ann Nutr Metab. 2011;59;1:59-63.
Domellöf M, Braegger C, Campoy C, Colomb V, Decsi T, Fewtrell M, et al. ESPGHAN Committee on Nutrition. Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr. 2014 Jan;58;1:119-29.
Bagley P, Shane B. Folate, Coates PM, Blackman MR, Betz JM, Cragg GM, et al., editors. Encyclopedia of Dietary Supplements. 2nd ed. Newyork:2015.p.645-652.
Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr. 2004 Mar;58;3:391-402.
Solovyev N, Drobyshev E, Blume B, Michalke B. Selenium at the Neural Barriers: AReview. Front Neurosci. 2021 Feb 5;15:630016. doi: 10.3389/fnins.2021.630016.
Chen J, Berry MJ. Selenium and selenoproteins in the brain and brain diseases. J Neurochem. 2003 Jul;86(1):1-12.
Ashrafi MR, Shams S, Nouri M, Mohseni M, Shabanian R, Yekaninejad MS, et al. A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia. 2007 Sep;48;9:1750-1755.
Guzel O, Uysal U, Arslan N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey. Eur J Paediatr Neurol. 2019 Jan;23;1:143-151.
Zimmerman AW, Lozzio CB. Interaction between selenium and zinc in the pathogenesis of anencephaly and spina bifida. Z Kinderchir. 1989 Dec;44 Suppl 1:48-50.
Behl S, Mehta S, Pandey MK. Abnormal Levels of Metal Micronutrients and Autism Spectrum Disorder: A Perspective Review. Front Mol Neurosci. 2020 Dec 10;13:586209.
Pillai R, Uyehara-Lock JH, Bellinger FP. Selenium and selenoprotein function in brain disorders. IUBMB Life. 2014 Apr;66;4:229-39.
Zalewski PD, Forbes IJ, Giannakis C. Physiological role for zinc in prevention of apoptosis (gene-directed death). Biochem Int. 1991 Aug;24;6:1093-101.
Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007 Jul 15;463;2:211-7.
Das M, Das R. Need of education and awareness towards zinc supplementation: A review. Int J Nutr Metab. 2012;4:45–50.
Lönnerdal B. Dietary factors influencing zinc absorption. J Nutr. 2000 May;130(5S Suppl):1378S-83S.
Tuormaa TE. Adverse effects of zinc deficiency: A review from the literature. J Orthomol Med. 1995;10:149–64.
Küry S, Dréno B, Bézieau S, Giraudet S, Kharfi M, Kamoun R, et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet. 2002 Jul;31;3:239-40.
Johnson MA, Kays SE. Copper: Its role in human nutrition. Nutr Today. 1990;25;1:6-14.
Jaiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010 Jun;257;6:869-81.
Tan JC, Burns DL, Jones HR. Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy. JPEN J Parenter Enteral Nutr. 2006 Sep-Oct;30;5:446-50.
Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS. CNS demyelination associated with copper deficiency and hyperzincemia. Neurology. 2002 Nov 12;59;9:1453-6.
Kumar N, Low PA. Myeloneuropathy and anemia due to copper malabsorption. J Neurol. 2004 Jun;251;6:747-9.
Mercer JF. The molecular basis of copper-transport diseases. Trends Mol Med. 2001 Feb;7;2:64-9.
Verrotti A, Carelli A, Coppola G. Epilepsy in children with Menkes disease: a systematic review of literature. J Child Neurol. 2014 Dec;29;12:1757-64.
Loudianos G, Lepori MB, Mameli E, Dessì V, Zappu A. Wilson's disease. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35;1:93-8.
Aliasgharpour M. A review on copper, ceruloplasmin and Wilson's disease. Int J Med Invest. 2015;4;4:344-347.
Incecık F, Herguner OM, Ozbek MN, Gungor S, Yılmaz M, Rizzo WB, Mert GG. Neuro-ichthyotic Syndromes: A Case Series. J Pediatr Neurosci. 2018 Jan-Mar;13:1:34-38.
Chan S, Gerson B, Subramaniam S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med. 1998 Dec;18;4:673-85.
Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015 Apr;3;4:286-95.
Pearce EN. Iodine deficiency in children. Endocr Dev. 2014;26:130-8.
Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med. 2005 Aug-Oct;26;4-5:353-62.
Tuschl K, Mills PB, Clayton PT. Manganese and the brain. Int Rev Neurobiol. 2013;110:277-312.
Goldbach HE, Wimmer MA. Boron in plants and animals: Is there a role beyond cell-wall structure? J. Plant Nutr. Soil Sci.-Zeitschrift Fur Pflanzenernahrung Und Bodenkunde. 2007;170;1:39–48.
Hunt CD. Regulation of enzymatic activity: one possible role of dietary boron in higher animals and humans. Biol Trace Elem Res. 1998 Winter;66;1-3:205-25.
Hunt CD. Biochemical effects of physiological amounts of dietary boron. J Trace Elem Exp Med. 1996;9;4:185–213.
Nielsen FH. Boron in human and animal nutrition. Plant Soil. 1997;193;1:199–208.
Penland JG. Dietary boron, brain function, and cognitive performance. Environ Health Perspect. 1994 Nov;102;Suppl 7:65-72.
Penland JG. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998 Winter;66;1-3:299-317.
Zdrojewicz Z, Popowicz E, Winiarski J. Nikiel - rola w organizmie człowieka i działanie toksyczne [Nickel - role in human organism and toxic effects]. Pol Merkur Lekarski. 2016 Aug;41;242:115-8.
Anke M, Angelow L, Glei M, Müller M, Illing H. The biological importance of nickel in the food chain. Fresenius J Anal Chem. 1995;352;1:92–6.
Anke M, Groppel B, Kronemann H, Grün M. Nickel--an essential element. IARC Sci Publ. 1984;53:339-65.
Poonkothai M, Vijayavathi S. Nickel as an essential element and a toxicant. Inter J Engin Sci and Tech. 2012;1;4:285–8.
Alexandrov PN, Pogue AI, Lukiw WJ. Synergism in aluminum and mercury neurotoxicity. Integr Food Nutr Metab. 2018 May;5;3:10.15761/IFNM.1000214.
Klotz K, Weistenhöfer W, Neff F, Hartwig A, van Thriel C, Drexler H. The Health Effects of Aluminum Exposure. Dtsch Arztebl Int. 2017 Sep 29;114;39:653-659.
Parkinson IS, Ward MK, Kerr DN. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis. J Clin Pathol. 1981;34;11:1285–1294.
Nday CM, Drever BD, Salifoglou T, Platt B. Aluminium interferes with hippocampal calcium signaling in a species-specific manner. J Inorg Biochem. 2010 Sep;104;9:919-27
Jankowska A, Madziar B, Tomaszewicz M, Szutowicz A. Acute and chronic effects of aluminum on acetyl-CoA and acetylcholine metabolism in differentiated and nondifferentiated SN56 cholinergic cells. J Neurosci Res. 2000 Nov 15;62;4:615-22
Kawahara M, Kato-Negishi M. Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses. Int J Alzheimers Dis. 2011 Mar 8;2011:276393.
